Search results
Found 691 matches for
Four investigators based at the Botnar Research Centre, NDORMS have been recently awarded National Institute for Health Research (NIHR) fellowships to further our understanding of a variety of musculoskeletal conditions and develop better methodology to support medical research.
OPTIMISE
OCTRU
Optimising Psoriatic Arthritis Therapy with Immunological Methods to Increase Standard Evaluation
PASHiOn
OCTRU SITU
Personalised Against Standard High tibial Osteotomy, a prospective multi-centre randomised controlled trial study
WISE
OCTRU Oxford Trauma
Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over
FRUITI
OCTRU Oxford Trauma
World Hip Trauma Evaluation - FRUITI: Fix or Replace Undisplaced Intracapsular fractures Trial of Interventions
PART
OCTRU SITU
A randomised controlled trial of Partial prostate Ablation versus Radical Treatment in intermediate risk, unilateral clinically localised prostate cancer
CRAFFT
OCTRU Oxford Trauma
Children’s Radius Acute Fracture Fixation Trial. A multi-centre prospective randomized non- inferiority trial of surgical reduction versus non-surgical casting for displaced distal radius fractures in children.
GRRAND-F
OCTRU RRIO
ACL SNNAP
Botnar OCTRU SITU
Comparison of the clinical and cost effectiveness of two management strategies for non-acute Anterior Cruciate Ligament (ACL) injury: rehabilitation versus surgical reconstruction
Meet the team
-
Daniel Prieto-Alhambra
Professor of Pharmaco- and Device Epidemiology
-
Maria Dudareva
NIHR Doctoral Research Fellow
-
Ioana Marian
Medical Statistician
Funded by
Find out more about
Similar stories
Professor Dani Prieto-Alhambra elected to ISPE Board of Directors
11 June 2021
Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.
New research from the Kennedy Institute of Rheumatology identifies a role for CD200 in limiting atherosclerosis
10 June 2021
A new study published in Circulation Research shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.
EPSRC funds research to avert an antibiotics apocalypse
7 June 2021
Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.
Research finds that surgery for Dupuytren’s disease is effective, but repeat operations come with higher risks
4 June 2021
Research by NDORMS Dominic Furniss, Professor of Plastic and Reconstructive Surgery, finds that surgery for the common hand disorder Dupuytren’s disease is safe and effective. However, repeat surgery could carry higher risks of complications such as finger amputation.
Celebrating World Clubfoot Day
3 June 2021
More than 30,000 children in Africa are born with clubfoot each year. With treatment simply not available where they live, many thousands of these children get no treatment and end up with severe deformities that make it hard and very painful to walk.
Repurposed drug can induce remission of inflammatory arthritis
20 May 2021
Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.